# WatchPAT SpO2 Validation Study

> **NCT06947447** · — · COMPLETED · sponsor: **Itamar-Medical, Israel** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** No intervention

## Key facts

- **NCT ID:** NCT06947447
- **Lead sponsor:** Itamar-Medical, Israel
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-04-21
- **Primary completion:** 2025-05-02
- **Final completion:** 2025-05-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2025-08-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06947447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06947447, "WatchPAT SpO2 Validation Study". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06947447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*